An international panel of pediatric rheumatologists created a new score to address a lack in the 4-item JADAS in quantifying the burden of extra-articular manifestations of juvenile idiopathic arthritis.
Researchers evaluated the use and performance of genomic risk scores for the clinical diagnosis of juvenile idiopathic arthritis.
Researchers characterized the blood gene signatures of male and female patients with systemic juvenile idiopathic arthritis.
Researchers assessed the incidence rate and type of serious adverse events in children with inflammatory rheumatic diseases receiving tocilizumab.
The FDA has approved Hulio® (adalimumab-fkjp; Mylan), a biosimilar to Humira® (adalimumab; AbbVie).
Researchers evaluated the early prostheses implantation in patients with juvenile idiopathic arthritis and the factors affecting implant survival.
The association between juvenile idiopathic arthritis and autism spectrum condition was explored.
Researchers evaluated the effectiveness and timing of DMARDs in the treatment of chil-dren with newly diagnosed polyarticular course juvenile idiopathic arthritis.
Researchers compared the frequency of joint and tendon disease on ultrasound and clinical examination in active juvenile idiopathic arthritis.
Researchers determined the long-term outcomes of the temporomandibular joint in juvenile idiopathic arthritis.
